Publications by authors named "Karin Barbin"

Claim this Profile
H
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells.
Christian Kellner, Joerg Bruenke, Heike Horner, Joerg Schubert, Michael Schwenkert, Karin Barbin

Cancer Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.
Jonas Winter, Karin Barbin, Camilla Bacci, Thomas Bunte

J Pharm Biomed Anal· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
Yvonne Guettinger, Karin Barbin, Matthias Peipp, Joerg Bruenke, Michael Dechant

J Immunol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies.
Karin Barbin, Julia Stieglmaier, Domenica Saul, Kristin Stieglmaier, Bernhard Stockmeyer

J Immunother· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
Michael Schwemmlein, Matthias Peipp, Karin Barbin, Domenica Saul, Bernhard Stockmeyer

Br J Haematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
Joerg Bruenke, Karin Barbin, Susanne Kunert, Peter Lang, Matthias Pfeiffer

Br J Haematol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.
Peter Lang, Karin Barbin, Tobias Feuchtinger, Johann Greil, Matthias Peipp

Blood· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.
Joerg Bruenke, Barbara Fischer, Karin Barbin, Katja Schreiter, Yvonne Wachter

Br J Haematol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.
Matthias Peipp, Domenica Saul, Karin Barbin, Joerg Bruenke, Susan J Zunino

J Immunol Methods· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis